Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.
Open accessAbstract
The reason why hyperinsulinemia is associated with essential hypertension is not known. To test the hypothesis of a pathophysiologic link mediated by the sympathetic nervous system, we measured the changes in forearm norepinephrine release, by using the forearm perfusion technique in conjunction with the infusion of tritiated NE, in patients with essential hypertension and in normal subjects receiving insulin intravenously (1 mU/kg per min) while maintaining euglycemia. Hyperinsulinemia (50-60 microU/ml in the deep forearm vein) evoked a significant increase in forearm NE release in both groups of subjects. However, the response of hypertensives was threefold greater compared to that of normotensives (2.28 +/- 45 ng.liter-1.min-1 in hypertensives and 0.80 +/- 0.27 ng.liter-1 in normals; P less than 0.01). Forearm glucose uptake rose to 5.1 +/- .7 mg.liter-1.min-1 in response to insulin in hypertensives and to 7.9 +/- 1.3 mg.liter-1.min-1 in normotensives (P less than 0.05). To clarify whether insulin action was due to a direct effect on muscle NE metabolism, in another set of experiments insulin was infused locally into the brachial artery to expose only the forearm tissues to the same insulin levels as in the systemic studies. During local hyperinsulinemia, forearm NE release remained virtually unchanged both in hypertensive and in normal subjects. Furthermore, forearm glucose disposal was activated to a similar extent in both groups (5.0 +/- 0.6 and 5.2 +/- 1.1 mg.liter-1.min-1 in hypertensives and in normals, respectively). These data demonstrate that: (a) insulin evokes an abnormal muscle sympathetic overactivity in essential hypertension which is mediated by mechanisms involving the central nervous system; and (b) insulin resistance associated with hypertension is demonstrable in the skeletal muscle tissue only with systemic insulin administration which produces muscle sympathetic overactivity. The data fit the hypothesis that the sympathetic system mediates the pathophysiologic link between hyperinsulinemia and essential hypertension.
AI snapshot
Written from the paper’s full text.
TL;DR
In patients with essential hypertension, systemic euglycemic hyperinsulinemia evoked a threefold greater increase in forearm skeletal muscle norepinephrine release than in normotensive controls. Local intra-arterial insulin did not change norepinephrine release in either group, suggesting the abnormal sympathetic response is centrally mediated rather than a direct muscle effect.
Key findings
- Systemic insulin infusion increased forearm NE release in both groups, but the absolute rise was threefold higher in hypertensives (2.28±0.45 vs. 0.80±0.27 ng·liter⁻¹·min⁻¹; P < 0.01); percent increases were 140% in hypertensives (P < 0.001) and 35% in normotensives (P < 0.05).
- During systemic insulin, forearm glucose uptake was lower in hypertensives than normotensives (5.1±0.7 vs. 7.9±1.3 mg·liter⁻¹·min⁻¹; P < 0.05), and whole-body glucose utilization was also lower (4.6±0.3 vs. 5.8±0.5 mg/kg per min; P < 0.05).
- During local intrabrachial insulin, forearm NE release remained virtually unchanged in both groups, while forearm glucose disposal was similar in hypertensives and normals (5.0±0.6 and 5.2±1.1 mg·liter⁻¹·min⁻¹, respectively).
- Forearm NE balance increased fourfold in hypertensives during systemic hyperinsulinemia (P < 0.05), whereas it was statistically indistinguishable from zero in normals.
Methods
- Forearm perfusion technique with tritiated norepinephrine tracer was used in 45 subjects: 21 normotensives and 24 patients with mild to moderate essential hypertension.
- Two protocols: systemic insulin infusion at 1 mU/kg per min for 120 min with euglycemia (12 normals, 14 hypertensives), or local intrabrachial insulin at 0.05 mU/kg per min (9 normals, 10 hypertensives); tracer subgroups received [³H]norepinephrine.
- Forearm NE kinetics were calculated from arterial–venous balance, fractional extraction, clearance, uptake, and release; comparisons used paired and unpaired t tests, with values reported as mean±SE.
Limitations
- The paper states that it cannot answer whether hyperinsulinemia is the primary defect leading to hypertension via sympathetic overactivity, and that an alternative primary sympathetic overactivity causing both hypertension and insulin resistance would be equally compatible with the data.
- The paper states that the mechanism of insulin-evoked muscle sympathetic overactivity is unknown and that a peripheral reflex such as a venous baroreflex or chemoreflex cannot be excluded.
- Evident from the text: sample sizes are small, especially for tracer subgroups (e.g., 8 normals and 7 hypertensives for systemic tracer studies; 5 and 5 for local tracer studies), and the local infusion model relies on adequate mixing, which was assessed in only 16 tested cases.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 35 cited sources checked · 0 supported · 0 flagged
- Findingown data
Systemic insulin infusion (1 mU/kg per min, euglycemic) evoked a significant increase in forearm norepinephrine release in both normotensive and hypertensive subjects.
“Hyperinsulinemia (50-60 jsU/ml in the deep forearm vein) evoked a significant increase in forearm NE release in both groups of subjects.”
Quote in the paperSubstantial claim - Findingown data
Forearm glucose uptake increased in response to intraarterial insulin infusion to a comparable extent in both groups.
“Forearm glucose uptake increased in response to intraarterial insulin infusion to a comparable ex- tent in both groups.”
Quote in the paperSubstantial claim - Findingown data
The mean absolute change in forearm NE release during hyperinsulinemia was threefold higher in hypertensive (2.28±0.45 ng·liter−1·min−1) than in normotensive subjects (0.80±0.27 ng·liter−1·min−1) (P < 0.01).
“The mean absolute change in forearm NE release during hyperinsulinemia was threefold higher in hypertensive (2.28±0.45ng.liter-' * min') than in normotensive subjects (0.80±0.27 ng liter-' * min-') (P < 0.01) (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
Arterial plasma FFA levels were not affected by local insulin (from 0.42±0.05 to 0.39±0.04 mmol in normal subjects and from 0.36±0.05 to 0.39±0.05 mmol in hypertensives).
“Arterial plasma FFA levels were not affected by local insulin (from 0.42±0.05 to 0.39±0.04mmol in normal sub- jects and from 0.36±0.05 to 0.39±0.05mmol in hypertensives).”
Quote in the paperNot a substantial claim - Findingnone given
Blood pressure remained unchanged throughout insulin infusion.
“since blood pressure remained unchanged throughout insulin infusion.”
Quote in the paperSubstantial claim
- Findingown data
During local hyperinsulinemia (intrabrachial insulin infusion), forearm norepinephrine release remained virtually unchanged in both hypertensive and normal subjects.
“During local hyperinsulinemia, forearm NE release re- mained virtually unchanged both in hypertensive and in normal subjects.”
Quote in the paperSubstantial claim - Findingown data
Comparable values of NE fractional extraction and clearance were found during both the basal state and the hyperinsulinemic period.
“Comparable values of NE fractional extraction and clearance were found during both the basal state and the hyperinsulin- emic period.”
Quote in the paperSubstantial claim - Findingown data
Blood pressure did not change significantly during systemic insulin infusion in either normotensive or hypertensive subjects.
“and did not change significantly during insu- lin infusion in both groups (Table II).”
Quote in the paperSubstantial claim - Findingown data
Arterial blood glucose levels remained unchanged in both groups during local, intrabrachial insulin infusion.
“Arterial blood glucose levels remained unchanged in both groups during local, intrabrachial insulin infusion.”
Quote in the paperSubstantial claim - Findingown data
During the hyperinsulinemic period, forearm NE release increased significantly by 35% in normotensives (P < 0.05).
“During the hyperinsuline- mic period, forearm NE release increased significantly by 35% in normotensives (P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
The marked increase in forearm NE release recorded in hypertensives during insulin infusion was not paralleled by significant changes in the hemodynamic parameters except for a small increase in heart rate.
“The marked increase in forearm NE release recorded in hypertensives during insulin infusion was not paralleled by sig- nificant changes in the hemodynamic parameters except for a small increase in heart rate.”
Quote in the paperSubstantial claim - Findingown data
Forearm blood flow increased in both groups during intrabrachial insulin infusion (0.05 < P < 0.1 in normotensives and P < 0.05 in hypertensives).
“Forearm blood flow in- creased in both groups during intrabrachial insulin infusion (0.05 < P < 0.1 in normotensives and P < 0.05 in hyperten- sives).”
Quote in the paperNot a substantial claim - Findingown data
The abnormal response of hypertensives was observed in circumstances where the forearm muscle tissue was exposed to a similar insulin concentration to that of normal subjects.
“This abnormal response of hypertensives was observed in cir- cumstances where the forearm muscle tissue was exposed to a similar insulin concentration to that of normal subjects.”
Quote in the paperSubstantial claim - Findingown data
In hypertensive patients, forearm norepinephrine balance increased fourfold during hyperinsulinemia.
“In contrast, in the hypertensive patients fore- arm NE balance increased fourfold during hyperinsulinemia (P”
Quote in the paperSubstantial claim - Findingown data
Whole body glucose utilization (M value) rose to 5.8±0.5 and 4.6±0.3 mg/kg per min in response to insulin in normotensives and hypertensives, respectively (P < 0.05).
“Whole body glucose utilization (M value) rose to 5.8±0.5 and 4.6±0.3mg/kg per min in response to insulin in normotensives and hypertensives, respectively (P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
In hypertensive patients, forearm NE release increased by 140% during the hyperinsulinemic period (P < 0.001).
“This response was considerably greater in the hypertensive patients in whom forearm NE re- lease increased by 140% (P < 0.001).”
Quote in the paperSubstantial claim - Findingown data
During local hyperinsulinemia, forearm glucose disposal was activated to a similar extent in hypertensive and normal subjects (5.0±0.6 and 5.2±1.1 mg/L/min, respectively).
“Furthermore, forearm glucose disposal was activated to a similar extent in both groups (5.0±0.6 and 5.2±1.1 mg.liter-' min-' in hypertensives and in normals, respec- tively).”
Quote in the paperSubstantial claim - Findingown data
Forearm NE balance remained unchanged during local insulin administration in both groups of subjects (Table V).
“Forearm NE balance remained unchanged during local insulin administration in both groups of subjects (Table V).”
Quote in the paperSubstantial claim - Findingown data
Basal forearm glucose uptake was not statistically different between normal and hypertensive subjects.
“Forearm glucose uptake in the basal state was not statistically different in normal and hypertensive subjects”
Quote in the paperNot a substantial claim - Findingown data
The increase in forearm norepinephrine release evoked by systemic insulin was about threefold greater in hypertensive patients than in normotensive subjects (2.28±45 vs 0.80±0.27 ng/L/min; P < 0.01).
“However, the response of hypertensives was threefold greater compared to that of normotensives (2.28±45 ng.liter-' * min' in hypertensives and 0.80±0.27ng.liter-' in normals; P < 0.01).”
Quote in the paperSubstantial claim - Findingown data
Forearm glucose uptake was similar in hypertensive and normotensive subjects during intrabrachial insulin infusion.
“Forearm glucose uptake was similar in hypertensive and normotensive subjects during intrabrachial insulin infusion”
Quote in the paperSubstantial claim - Findingown data
During systemic insulinization, forearm glucose uptake was significantly lower in hypertensives than in normal subjects.
“On the other hand, during systemic insulinization, when indirect mechanisms also intervene (28), forearm glucose uptake was significantly lower in hypertensives than in normal subjects.”
Quote in the paperSubstantial claim - Interpretationreasoning
The insulin-induced sympathetic overactivity observed in the study represents an underestimation of what may potentially occur in the day-life of hypertensive patients.
“Therefore, the phe- nomenon here revealed of insulin-induced sympathetic over- activity represents, in all likelihood, an underestimation of what may potentially occur in the day-life of hypertensive patients.”
Quote in the paperSubstantial claim - Interpretationown data
It is unlikely that insulin elicited an arterial baroreflex.
“Regarding the latter, it seems quite unlikely that insulin may have elicited an arterial baroreflex since blood pressure remained unchanged throughout insulin infusion.”
Quote in the paperSubstantial claim - Premisecitation
Insulin may efficiently antagonize NE action on smooth muscle cells.
“This is only in part surprising since several studies have shown that insulin may efficiently antagonize NE action on smooth muscle cells (41, 42).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41]
Not checked in the free run.
- cites [42]
Not checked in the free run.
- Premisecitation
In hypertensive patients, glucose intolerance and insulin resistance with attendant hyperinsulinemia have been amply demonstrated.
“(a) in hypertensive patients, glucose intolerance and insulin resistance with attendant hyperinsulinemia have been amply demonstrated (3, 9, 10);”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [3]
Not checked in the free run.
- cites [9]
Not checked in the free run.
- cites [10]
Not checked in the free run.
- Premisecitation
Skeletal muscle is an important site of insulin action in general.
“The study was performed at skeletal muscle level as this tissue is an important site of insulin action in general and is specifically responsible for insulin resistance in human hyper- tension (21).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21]
Not checked in the free run.
- Premisecitation
Skeletal muscle is specifically responsible for insulin resistance in human hypertension.
“The study was performed at skeletal muscle level as this tissue is an important site of insulin action in general and is specifically responsible for insulin resistance in human hyper- tension (21).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21]
Not checked in the free run.
- Premisecitation
An increased sympathetic activity in hypertensive patients has been previously reported only in response to experimental maneuvers.
“An increased sympathetic activity in hyper- tensive patients has been previously reported only in response to experimental maneuvers (13,14).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13]
Not checked in the free run.
- cites [14]
Not checked in the free run.
- Study design and conductown data
The validity of the local insulin infusion model is supported by the stability of arterial concentrations of insulin-sensitive substrates, such as glucose and particularly FFA, during local insulin infusion.
“The validity of the model employed is supported by the fact that the arterial concentration of insulin- sensitive substrates, such as glucose and particularly FFA, re- mained stable during local insulin infusion.”
Quote in the paperSubstantial claim - Premisecitation
Substantial evidence favoring a causal role of insulin comes essentially from studies in fructose-fed rats.
“Substantial evidence favoring a causal role of insulin comes essentially from the studies in fructose-fed rats (4-6).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [4]
Not checked in the free run.
- cites [5]
Not checked in the free run.
- cites [6]
Not checked in the free run.
- Premisecitation
Sympathetic overactivity may antagonize insulin action.
“and may antagonize insulin action (16)(17)(18)(19)(20).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [16]
Not checked in the free run.
- cites [17]
Not checked in the free run.
- cites [18]
Not checked in the free run.
- Interpretationreasoning
The data fit the hypothesis that the sympathetic system mediates the pathophysiologic link between hyperinsulinemia and essential hypertension.
“The data fit the hypothesis that the sympathetic system mediates the pathophysiologic link be- tween hyperinsulinemia and essential hypertension.”
Quote in the paperSubstantial claim - Premisecitation
In the fructose-fed rat model, the sequence of insulin resistance, hyperinsulinemia, and hypertension may be interrupted by preventing either insulin resistance with physical exercise or hyperinsulinemia with somatostatin.
“and this sequence may be interrupted by preventing either in- sulin resistance with physical exercise or hyperinsulinemia with somatostatin (5,6).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5]
Not checked in the free run.
- cites [6]
Not checked in the free run.
- Interpretationown data
The increase in NE release from forearm muscle in response to hyperinsulinemia is considerably more pronounced in patients with essential hypertension than in normal subjects.
“More important, this response is considerably more pro- nounced in patients with essential hypertension.”
Quote in the paperSubstantial claim- Rests on an assumption: Forearm norepinephrine release measured by the [3H]norepinephrine infusion technique reflects skeletal muscle sympathetic nerve activity.
- Premisecitation
Skeletal muscle is involved in catecholamine-induced insulin resistance in humans.
“It must be also remarked that the skeletal muscle is involved in catecholamine-induced insulin resistance in hu- mans (19,22).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19]
Not checked in the free run.
- cites [22]
Not checked in the free run.
- Interpretationown data
Physiologic hyperinsulinemia increases NE release from the forearm muscle in normal humans.
“Our results demonstrate that physiologic hyperinsulinemia increases NE release from the forearm muscle in normal hu- mans.”
Quote in the paperSubstantial claim- Rests on an assumption: Forearm norepinephrine release measured by the [3H]norepinephrine infusion technique reflects skeletal muscle sympathetic nerve activity.
- Study design and conductown data
In the local intraarterial infusion experiments, lack of significant streaming (dye concentration difference <20%) occurred in almost 90% of tested cases (n=16).
“We found that lack of significant streaming (dye concentra- tion difference < 20%) occurred in almost 90% of the tested cases (n= 16).”
Quote in the paperSubstantial claim - Premisecitation
Microneurographic studies have provided convincing evidence that insulin affects muscle sympathetic nerves.
“More convincing evidence has been recently provided by microneurographic studies documenting an insulin effect on muscle sympathetic nerves (12,33).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12]
Not checked in the free run.
- cites [33]
Not checked in the free run.
- Premisecitation
Increased sympathetic activity in essential hypertension, particularly in the mild form of young hypertensives, has been documented by a variety of approaches.
“(c) increased sympa- thetic activity in essential hypertension, particularly in the mild form of young hypertensives, has been documented by a vari- ety of approaches (13,14);”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13]
Not checked in the free run.
- cites [14]
Not checked in the free run.
- Premisecitation
In normal individuals, insulin evokes sympathetic overactivity.
“(b) in normal individuals, insulin evokes sympathetic overactivity (1 1, 12);”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 1 1, 12
Not checked in the free run.
- Interpretationown data
There is no difference in the direct effect of insulin on skeletal muscle tissue with regard to glucose uptake between hypertensive and normotensive subjects.
“demonstrating no difference in the direct effect ofthe hormone on skeletal muscle tissue, with regard to glucose uptake.”
Quote in the paperSubstantial claim - Interpretationown data
The current study provides evidence for an abnormal muscle sympathetic activity reflexly evoked by insulin in essential hypertension.
“In conclusion, the current study provides evidence for an abnormal muscle sympathetic activity reflexly evoked by insu- lin in essential hypertension.”
Quote in the paperSubstantial claim- Rests on an assumption: Forearm norepinephrine release measured by the [3H]norepinephrine infusion technique reflects skeletal muscle sympathetic nerve activity.
- May combine two claims. 17
- Classified as probably not a substantial claim. 8
May combine two claims.
Findingown dataHeart rate was comparable in the two groups in basal conditions and increased slightly during hyperinsulinemia only in hypertensive patients (P < 0.05).
“Heart rate was comparable in the two groups in basal conditions and increased slightly during hyperinsulinemia only in hypertensive patients (P < 0.05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn normal subjects, forearm norepinephrine balance was statistically indistinguishable from zero both in the basal state and during systemic insulin infusion.
“In normal subjects, forearm NE balance was statistically indistinguishable from zero both in the basal state and during insulin infusion.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSystolic and diastolic blood pressures were significantly higher in hypertensive patients than in normotensive subjects.
“As expected, systolic and diastolic blood pressures were significantly higher in hypertensives than in normotensives”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth forearm NE uptake and NE release were totally unaffected by local forearm insulinization.
“Both forearm NE uptake and NE release were totally unaffected by local forearm insulinization.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPlasma insulin concentration in the deep forearm vein was similar in the basal state in the two groups and increased to a comparable extent during systemic insulin infusion.
“Plasma insulin concentration in the deep forearm vein was similar in the basal state in the two groups and increased to a comparable extent during systemic insulin infusion.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningForearm NE uptake was similar in the basal state and increased comparably in the two groups during insulin infusion (P < 0.05).
“Accordingly, forearm NE uptake was similar in the basal state and increased comparably in the two groups during insulin infusion (P < 0.05).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDuring systemic insulin infusion, forearm glucose uptake increased in both groups, but the level attained was significantly lower in hypertensive patients than in normotensive subjects (5.1±0.7 vs 7.9±1.3 mg/L/min; P < 0.05).
“Forearm glucose uptake rose to 5.1±.7 mg * liter-' * min-in response to insulin in hypertensives and to 7.9±1.3mg.liter' -min' in normotensives (P < 0.05).”
- Also stated in: § Downers Grove, IL). · plain
“Forearm glucose uptake in the basal state was not statistically different in normal and hypertensive subjects and increased considerably in response to insulin infusion in both groups.However, the levels attained in hypertensive patients were significantly lower than those ob- served in control subjects (P < 0.05) (Table III).”
Quote in the paperNot a substantial claim- Also stated in: § Downers Grove, IL). · plain
May combine two claims.
Findingown dataVenous plasma insulin levels increased to the same extent after insulin whereas systemic insulin concentration remained stable at its basal level.
“Ve- nous plasma insulin levels increased to the same extent after insulin whereas systemic insulin concentration remained stable at its basal level.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBasal arterial blood glucose concentrations were similar in normal and hypertensive subjects and remained virtually unchanged during systemic insulin infusion in both groups.
“As shown in Table III, basal arterial blood glucose concen- trations were similar in normal and hypertensive subjects, and remained virtually unchanged during insulin infusion in both groups.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEstimated forearm blood flow was similar in the two groups in the basal state and increased slightly but not significantly after systemic insulin administration.
“Estimated forearm blood flow was similar in the two groups in the basal state and increased slightly but not signifi- cantly after insulin administration (Table III).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataInsulin evokes an abnormal muscle sympathetic overactivity in essential hypertension that is mediated by mechanisms involving the central nervous system.
“These data demonstrate that: (a) insulin evokes an ab- normal muscle sympathetic overactivity in essential hyperten- sion which is mediated by mechanisms involving the central nervous system;”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the fructose-fed rat model, insulin resistance, hyperinsulinemia, and hypertension develop.
“In this model, insu- lin resistance, hyperinsulinemia, and hypertension develop”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5]
Not checked in the free run.
- cites [6]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA program of physical activity or body weight control leads to a parallel reduction of hyperinsulinemia and blood pressure levels.
“Particularly relevant is the observation that a program of physical activity or body weight control leads to a parallel reduction of hyperinsulinemia and blood pressure levels (7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7]
Not checked in the free run.
May combine two claims.
Interpretationown dataAll of the insulin effect on muscle NE metabolism seen with systemic insulinization is mediated either by central mechanisms involving the hypothalamic nuclei or by a peripheral reflex.
“This leads to the conclu- sion that all of the insulin effect on muscle NE metabolism, seen with systemic insulinization, is mediated either by central mechanisms involving the hypothalamic nuclei or by a periph- eral reflex.”
Quote in the paperSubstantial claim- Rests on an assumption: Forearm norepinephrine release measured by the [3H]norepinephrine infusion technique reflects skeletal muscle sympathetic nerve activity.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the offspring of essential hypertensive parents, insulin resistance and hyperinsulinemia are demonstrable before the development of high blood pressure.
“Of interest is also the recent observation that in the offspring of essential hyperten- sive parents insulin resistance and hyperinsulinemia are de- monstrable before the development of high blood pressure (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8]
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationSympathetic overactivity may be potentially responsible for elevated blood pressure.
“(d) sympathetic overactivity may be potentially responsible for elevated blood pressure (15)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn vitro insulin affects NE uptake by atrial strips.
“Evi- dence to support this last hypothesis comes from the observa- tion that in vitro insulin affects NE uptake by the atrial strips (39).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39]
Not checked in the free run.
May combine two claims.
Interpretationown dataInsulin resistance associated with hypertension is demonstrable in skeletal muscle tissue only with systemic insulin administration, which produces muscle sympathetic overactivity.
“and (b) insulin resistance associated with hypertension is demonstrable in the skeletal muscle tissue only with systemic insulin administration which produces muscle sympathetic overactivity.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationNE can induce vascular smooth muscle cell polyploidy independent of blood pressure elevation.
“and that NE can in- duce vascular smooth muscle cell polyploidy independent of blood pressure elevation (47).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47]
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningThe exaggerated sympathetic activation induced by systemic insulinization in hypertensives may play a causal role in the impaired glucose uptake by the muscle tissue.
“Alternatively, the data may indicate that the exaggerated sympathetic activation induced by systemic insulinization in hypertensives may play a causal role in the impaired glucose uptake by the muscle tissue.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThese are potential factors that may lead to structural alterations in the arterial vessels, thus reducing the lumen area, amplifying the vasoconstrictor response to contractile agents, and limiting vasodilation.
“These are potential factors that may lead to structural alterations in the arterial vessels, thus reducing the lumen area, amplifying the vasoconstrictor re- sponse to contractile agents, and limiting vasodilation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe abnormal sympathetic response to insulin may further aggravate insulin resistance and hyperinsulinemia, thus acting as a self-perpetuating mechanism in essential hypertension.
“Whatever the initial event, our data also point out the possibility that the abnormal sympathetic response to insulin may further aggravate insulin resistance and hypennsu- linemia, thus acting as a self-perpetuating mechanism in essen- tial hypertension.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted).
InterpretationcitationMuscle insulin resistance in hypertension is entirely mediated by the indirect component of insulin action.
“The different response of muscle glucose uptake to local or systemic insulin may suggest that muscle insulin resistance in hypertension is entirely mediated by the indirect component of insulin action (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Not checked in the free run.
May combine two claims.
PremisecitationThe sympathetic nervous system promotes the growth of vascular muscle fibers and myocardium.
“In this context, it is pertinent to recall that the sympa- thetic nervous system promotes the growth of vascular muscle fibers (43, 44) and myocardium (45,46)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [43]
Not checked in the free run.
- cites [44]
Not checked in the free run.
- cites [45]
Not checked in the free run.
The paper relies on this without support.
The reason why hyperinsulinemia is associated with essential hypertension is not known.
“The reason why hyperinsulinemia is associated with essential hypertension is not known.”
The paper relies on this without support.
The available clinical data support the concept that insulin and human hypertension must be linked by pathophysiologic mechanisms.
“The available clinical data, however, tend to support the concept that the two factors must be linked by pathophysiologic mechanisms.”
The paper relies on this without support.
The effluent venous blood from the deep antecubital vein drains predominantly muscle tissue.
“Under these conditions, the effluent venous blood drained predominantly muscle tissue.”
The paper relies on this without support.
Forearm norepinephrine release measured by the [3H]norepinephrine infusion technique reflects skeletal muscle sympathetic nerve activity.
“In conclusion, the current study provides evidence for an abnormal muscle sympathetic activity reflexly evoked by insu- lin in essential hypertension.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In humans, acute euglycemic hyperinsulinemia stimulates both sympathetic efferent activity and blood flow in skeletal muscle.
“Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [8]
The Introduction reports that intravenous insulin during euglycemia increased forearm norepinephrine release in both normal and hypertensive subjects. In the systemic-insulinization results (Table III), forearm blood flow increased only slightly and not significantly, so the paper does not establish the claimed vasodilation under those conditions. The Discussion says the mechanism of insulin-evoked muscle sympathetic overactivity is not known. (LLM, conf=0.88)
Experimental — accuracy not yet measuredA central neural action of insulin may also contribute to stimulation of sympathetic outflow in this setting.
“Alternatively, a central neural action of insulin may also contribute to stimulation of sympathetic outflow in this setting (8, 40-43).”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [8]
In humans, local intraarterial insulin infusion, in contrast to systemic intravenous infusion, did not have any stimulatory effect on sympathetic activity in skeletal muscle.
“findings in humans, showing that local intraarterial insulin infusion, in contrast to systemic intravenous infusion, did not have any stimulatory effect on sympathetic activity in skeletal muscle (15).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [15]
In hypertensive insulin-resistant humans, insulin augments stimulation of norepinephrine release into forearm tissue.
“in hypertensive insulin-resistant humans, Lembo et al. (15) recently provided evidence for augmented stimulation of norepinephrine release into forearm tissue by insulin.”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as Lembo et al. (15)
Insulin-induced increases in sympathetic activity and norepinephrine release in skeletal muscle are substantially exaggerated in hypertensive patients.
“In contrast, Lembo et al84 demonstrated that insulin-induced increases in sympathetic activity and norepinephrine release in skeletal muscle are substantially exaggerated in hypertensive patients (Figure 3, right panel).”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
NE-release calculation has its subtraction reversed
MinorUnder the paper's stated sign convention, net NE balance is uptake minus release. Release therefore equals uptake minus net balance, not net balance minus uptake as the calculation describes.
“Once FNU was calculated, forearm NE release was easily obtained by subtracting FNU from the net NE balance.”
“Positive or nega- tive balance values indicate uptake or release, respectively.”
Cites
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344 · see citing works
Anton, A. H., & Sayre, D. F. (1962) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26438-2 · Cited by 2,271 · see citing works
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465 · see citing works
Desbuquois, B., & Aurbach, G. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-732 · Cited by 1,301 · see citing works
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143 · see citing works
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075 · see citing works
Fructose-induced insulin resistance and hypertension in rats.
Hwang, I. S., Ho, H., Hoffman, B. B., & Reaven, G. M. (1987) · Hypertension · doi:10.1161/01.hyp.10.5.512 · Cited by 885 · see citing works
Recommendations for Human Blood Pressure Determination by Sphygmomanometers
Kirkendall, W. M., Burton, A. C., Epstein, F. H., & Freis, E. D. (1967) · Circulation · doi:10.1161/01.cir.36.6.980 · Cited by 882 · see citing works
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632 · see citing works
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
Rocchini, A. P., Key, J., Bondie, D., Chico, R., Moorehead, C., Katch, V., & Martin, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210905 · Cited by 621 · see citing works
Simpson, P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111023 · Cited by 618 · see citing works
Epinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 560 · see citing works
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
Shen, D. C., Shieh, S.-M., Fuh, M. M.-T., WU, D.-A., Chen, Y. I., & Reaven, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420 · see citing works
LANDSBERG, L. (1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068066 · Cited by 373 · see citing works
Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man
Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109714 · Cited by 340 · see citing works
SERUM-INSULIN IN ESSENTIAL HYPERTENSION AND IN PERIPHERAL VASCULAR DISEASE
Welborn, T. A., Breckenridge, A., Rubinstein, A. H., Dollery, C. T., & Fraser, T. R. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92132-5 · Cited by 321 · see citing works
METROPOLITAN LIFE INSURANCE COMPANY
Ramsay, E. M. (1975) · Nursing Research · doi:10.1097/00006199-197505000-00037 · Cited by 317 · see citing works
BERGEL, D. H. (1991) · Cardiovascular Research · doi:10.1093/cvr/25.8.704 · Cited by 305 · see citing works
A new colorimetric micro-determination of free fatty acids in serum
Noma, A., Okabe, H., & Kita, M. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90468-3 · Cited by 233 · see citing works
Ferrari, P., Weidmann, P. U., Shaw, S., Giachino, D., Riesen, W., Allemann, Y., & Heynen, G. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90211-f · Cited by 207 · see citing works
Berne, C., Fagius, J., & Niklasson, F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114313 · Cited by 182 · see citing works
Effect of insulin on central catecholamines
Sauter, A., Goldstein, M., Engel, J., & Ueta, K. (1983) · Brain Research · doi:10.1016/0006-8993(83)90691-1 · Cited by 181 · see citing works
Growth‐stimulating effect of catecholamines on rat aortic smooth muscle cells in culture
Blaes, N., & Boissel, J. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041160207 · Cited by 169 · see citing works
Trophic effects of peripheral adrenergic nerves on vascular structure.
Bevan, R. D. (1984) · Hypertension · doi:10.1161/01.hyp.6.6_pt_2.iii19 · Cited by 163 · see citing works
Postprandial hyperinsulinemia in patients with mild essential hypertension.
SINGER, P. A., Gödicke, W., Voigt, S., Hajdu, I., & Weiss, M. (1985) · Hypertension · doi:10.1161/01.hyp.7.2.182 · Cited by 160 · see citing works
Somatostatin inhibition of fructose-induced hypertension.
Reaven, G. M., Ho, H., & Hoffmann, B. B. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.117 · Cited by 158 · see citing works
Attenuation of fructose-induced hypertension in rats by exercise training.
Reaven, G. M., Ho, H., & Hoffman, B. B. (1988) · Hypertension · doi:10.1161/01.hyp.12.2.129 · Cited by 152 · see citing works
Andres, R., Zierler, K. L., Anderson, H., STAINSBY, W. N., Cader, G., Ghrayyib, A. S., & Lilienthal, J. L. (1954) · Journal of Clinical Investigation · doi:10.1172/jci102919 · Cited by 147 · see citing works
Impaired insulin action on skeletal muscle metabolism in essential hypertension.
Natali, A., Santoro, D., Palombo, C., Cerri, M., Ghione, S., & Ferrannini, E. (1991) · Hypertension · doi:10.1161/01.hyp.17.2.170 · Cited by 146 · see citing works
Reaven, G. M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90028-v · Cited by 144 · see citing works
Impaired Suppression of Sympathetic Activity during Fasting in the Gold Thioglucose-treated Mouse
Young, J. K., & Landsberg, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109761 · Cited by 130 · see citing works
Yagi, S., Takata, S., Kiyokawa, H., Yamamoto, M., Noto, Y., Ikeda, T., & Hattori, N. (1988) · Diabetes · doi:10.2337/diab.37.8.1064 · Cited by 105 · see citing works
Landsberg, L., & Young, J. B. (1985) · PubMed · Cited by 103 · see citing works
The Effect of Insulin on Vascular Reactivity to Norepinephrine
Alexander, W. D., & Oake, R. J. (1977) · Diabetes · doi:10.2337/diab.26.7.611 · Cited by 93 · see citing works
Skeletal muscle is a primary site of insulin resistance in essential hypertension
Capaldo, B., Lembo, G., Napoli, R., Rendina, V., ALBANO, G., Saccà, L., & Trimarco, B. (1991) · Metabolism · doi:10.1016/0026-0495(91)90036-v · Cited by 86 · see citing works
Self-citationSaccà, L., Cicala, M., Trimarco, B., Ungaro, B., & Vigorito, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110583 · Cited by 73 · see citing works
Self-citationCircumventricular Organs: Receptors and Mediators of Direct Peptide Hormone Action on Brain
van Houten, M., & Posner, B. I. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50015-3 · Cited by 62 · see citing works
Mechanisms of Epinephrine-induced Glucose Intolerance in Normal Humans
Saccà, L., Vigorito, C., Cicala, M., Ungaro, B., & Sherwin, R. S. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110451 · Cited by 59 · see citing works
Self-citationTrimarco, B., Ricciardelli, B., LUCA, N. D., Simone, A. D., Cuocolo, A., Galva, M. D., Picotti, G. B., & Condorelli, M. (1985) · Circulation · doi:10.1161/01.cir.72.1.38 · Cited by 57 · see citing works
Self-citationThe effect of insulin on vascular reactivity to norepinephrine
Alexander, W. D., & Oake, R. J. (1977) · Diabetes · doi:10.2337/diabetes.26.7.611 · Cited by 48 · see citing works
INSULIN‐INDUCED ENHANCEMENT OF UPTAKE OF NORADRENALINE IN ATRIAL STRIPS
Bhagat, B. D., Burke, W. J., & Dhalla, N. S. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb09975.x · Cited by 37 · see citing works
Insulin antagonistic effects of epinephrine and glucagon in the dog.
Sacc�, L., Eigler, N. L., Cryer, P. E., & Sherwin, R. S. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.6.e487 · Cited by 37 · see citing works
Self-citationCatecholamine-induced polyploidization in vascular smooth muscle cells.
Yamori, Y., Mano, M., Nara, Y., & Horie, R. (1987) · PubMed · Cited by 34 · see citing works
Trimarco, B., Lembo, G., LUCA, N. D., Volpe, M., Ricciardelli, B., Condorelli, G., Rosiello, G., & Condorelli, M. (1989) · Circulation · doi:10.1161/01.cir.80.4.883 · Cited by 32 · see citing works
Self-citationYagi, S., Takata, S., Kiyokawa, H., et al. (1988) · Diabetes · doi:10.2337/diabetes.37.8.1064 · Cited by 32 · see citing works
Saccà, L., PEREZ, G., Cartenì, G., & Rengo, F. (1977) · Endocrinology · doi:10.1210/endo-101-4-1016 · Cited by 30 · see citing works
Self-citationCapaldo, B., Napoli, R., Bonito, P. D., ALBANO, G., & Saccà, L. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.3.e389 · Cited by 17 · see citing works
Self-citationThe Sympathoadrenal System in the Maintenance of Elevated Arterial Pressure
Izzo, J. L. (1984) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198400063-00011 · Cited by 9 · see citing works
Effects of Theophylline on Glucose Kinetics in Normal and Sympathectomized Rats
Saccà, L., Perez, G., Rengo, F., Pascucci, I., & Condorelli, M. (1975) · Diabetes · doi:10.2337/diab.24.3.249 · Cited by 9 · see citing works
Self-citationEffects of theophylline on glucose kinetics in normal and sympathectomized rats
Sacca, L., Perez, G., Rengo, F., et al. (1975) · Diabetes · doi:10.2337/diabetes.24.3.249 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473 · see citing works
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 873 · see citing works
Diabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 696 · see citing works
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616 · see citing works
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease
Jia, G., & Sowers, J. R. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17981 · Cited by 460 · see citing works
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425 · see citing works
Scherrer, U., & Sartori, C. (1997) · Circulation · doi:10.1161/01.cir.96.11.4104 · Cited by 371 · see citing works
Blood flow and muscle metabolism: a focus on insulin action
Clark, M. G., Wallis, M. G., Barrett, E. J., Keske, M. A., Richards, S. M., Clerk, L. H., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2002 · Cited by 355 · see citing works
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension
Grassi, G. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 340 · see citing works
Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116542 · Cited by 321 · see citing works
Hypertension and diabetes: co-prediction and time trajectories
Tsimihodimos, V., González-Villalpando, C., Meigs, J., & Ferrannini, E. (2018) · HYPERTENSION · doi:10.1161/hypertensionaha.117.10546 · Cited by 227 · see citing works
Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117242 · Cited by 285 · see citing works
Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
Ecder, T., & Schrier, R. W. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.13 · Cited by 274 · see citing works
Insulin-induced vasodilatation: physiology or pharmacology?
Yki‐Järvinen, H., & Utriainen, T. (1998) · Diabetologia · doi:10.1007/s001250050919 · Cited by 260 · see citing works
Sympathetic regulation of vascular function in health and disease
Bruno, R. M., Ghiadoni, L., Seravalle, G., Dell’Oro, R., Taddei, S., & Grassi, G. M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00284 · Cited by 241 · see citing works
Obesity and adipokines: effects on sympathetic overactivity
Smith, M. M., & Minson, C. T. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221036 · Cited by 237 · see citing works
Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes
Mancusi, C., Izzo, R., Gioia, G. D., Losi, M. A., Barbato, E., & Morisco, C. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00408-8 · Cited by 232 · see citing works
Jankauskas, S. S., Kansakar, U., Varzideh, F., Wilson, S. M., Mone, P., Lombardi, A., Gambardella, J., & Santulli, G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154910 · Cited by 221 · see citing works
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
Sano, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.12.004 · Cited by 188 · see citing works
Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin
Rahmouni, K., Morgan, D. A., Morgan, G. M., Liu, X., Sigmund, C. D., Mark, A. L., & Haynes, W. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21737 · Cited by 187 · see citing works
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Sowers, J. R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.691 · Cited by 184 · see citing works
SYMPATHETIC NERVOUS SYSTEM, DIABETES, AND HYPERTENSION
Perin, P. C., Maule, S. V., & Quadri, R. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100001196 · Cited by 175 · see citing works
Posttraumatic stress disorder: A metabolic disorder in disguise?
Michopoulos, V., Vester, A., & Neigh, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.038 · Cited by 152 · see citing works
Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese
Tatsumi, Y., & Ohkubo, T. (2017) · Hypertension Research · doi:10.1038/hr.2017.67 · Cited by 148 · see citing works
Mikhail, N. E., Golub, M. S., & Tuck, M. L. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70008-3 · Cited by 146 · see citing works
The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms
Bonsignore, M. R., Marrone, O., Insalaco, G., & Bonsignore, G. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07040786 · Cited by 143 · see citing works
Akt Mediates the Cross-Talk Between β-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes
Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Condorelli, G., Sadoshima, J., & Trimarco, B. (2005) · Circulation Research · doi:10.1161/01.res.0000152968.71868.c3 · Cited by 141 · see citing works
Self-citationNeurogenic Abnormalities in Masked Hypertension
Grassi, G. M., Seravalle, G., Trevano, F. Q., Dell’Oro, R., Bolla, G. B., Cuspidi, C., Arenare, F., & Mancia, G. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092528 · Cited by 139 · see citing works
Acute noradrenergic activation induces insulin resistance in human skeletal muscle
Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e242 · Cited by 136 · see citing works
Self-citationMechanisms of Insulin Action on Sympathetic Nerve Activity
Muntzel, M. S., Anderson, E. A., Johnson, A. K., & Mark, A. L. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087053 · Cited by 135 · see citing works
Clinical association between non‐alcoholic fatty liver disease and the development of hypertension
Ryoo, J., Suh, Y. J., Shin, H. C., Cho, Y. K., Choi, J., & Park, S. K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12643 · Cited by 132 · see citing works
Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans.
Scherrer, U., Vollenweider, P., Randin, D., Jéquier, E., Nicod, P., & Tappy, L. (1993) · Circulation · doi:10.1161/01.cir.88.2.388 · Cited by 131 · see citing works
Chapman, M. J., & Sposito, A. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.004 · Cited by 123 · see citing works
The Inter-Relationship between Insulin Resistance and Hypertension
Salvetti, A., Brogi, G., Legge, V. D., & Bernini, G. (1993) · Drugs · doi:10.2165/00003495-199300462-00024 · Cited by 119 · see citing works
Scherrer, U., & Sartori, C. S. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420315 · Cited by 117 · see citing works
Buchanan, T. A., Thawani, H., Kades, W. W., Modrall, J. G., Weaver, F. A., Laurel, C., Poppiti, R., Xiang, A. H., & Hsueh, W. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116642 · Cited by 114 · see citing works
Perturbed Autonomic Nervous System Function in Metabolic Syndrome
Tentolouris, N., Argyrakopoulou, G., & Katsilambros, N. L. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8022-5 · Cited by 115 · see citing works
Age-Related Impairment in Insulin Release
Santulli, G., Lombardi, A., Sorriento, D., Anastasio, A., Giudice, C. D., Formisano, P., Bèguinot, F., Trimarco, B., Miele, C., & Iaccarino, G. (2012) · Diabetes · doi:10.2337/db11-1027 · Cited by 110 · see citing works
Self-citationOBESITY AND AUTONOMIC FUNCTION IN ADOLESCENCE
Riva, P., Martini, G., Rabbia, F., Milan, A., Paglieri, C., Chiandussi, L., & Veglio, F. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100001197 · Cited by 108 · see citing works
Sartori, C. S., Lepori, M., & Scherrer, U. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.009 · Cited by 106 · see citing works
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Mendizábal, Y., Llorens, S., & Nava, E. (2013) · International Journal of Hypertension · doi:10.1155/2013/230868 · Cited by 103 · see citing works
New model for the regulation of energy balance and adiposity by the central nervous system
Kaiyala, K., Woods, S. C., & Schwartz, M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.5.1123s · Cited by 98 · see citing works
Napoli, R., Cozzolino, D., Guardasole, V., Angelini, V., Zarra, E., Matarazzo, M., Cittadini, A., Saccà, L., & Torella, R. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.010 · Cited by 99 · see citing works
Self-citationInsufficient Control of Blood Pressure and Incident Diabetes
Izzo, R., SIMONE, G. D., Chinali, M., Iaccarino, G., Trimarco, V., Rozza, F., Giudice, R., Trimarco, B., & LUCA, N. D. (2009) · Diabetes Care · doi:10.2337/dc08-1881 · Cited by 96 · see citing works
Self-citationCipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B., & Iaccarino, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp252 · Cited by 94 · see citing works
Self-citationHsueh, W. A., & Buchanan, T. A. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30105-1 · Cited by 91 · see citing works
Manzella, D. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.11.006 · Cited by 89 · see citing works
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
Natali, A., Bonadonna, R. C., Santoro, D., Galvan, A. Q., Baldi, S., Frascerra, S., Palombo, C., Ghione, S., & Ferrannini, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117498 · Cited by 89 · see citing works
Sechi, L. A. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917090-00001 · Cited by 86 · see citing works
Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice
Roncon‐Albuquerque, R., Moreira-Rodrigues, M., Faria, B., Ferreira, A. P., Cerqueira, C., Lourenço, A. P., Pestana, M., HAFE, P. V., & Leite-Moreira, A. F. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.021 · Cited by 84 · see citing works
Systemic hypertension and coronary artery disease: the link
Lembo, G., Morisco, C., Lanni, F., Barbato, E., Vecchione, C., Fratta, L., & Trimarco, B. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00484-6 · Cited by 82 · see citing works
Self-citationHyperinsulinemia in glucose-tolerant women with preeclampsia A controlled study
Abundis, E. M. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00448-3 · Cited by 88 · see citing works
Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients
Seravalle, G., Colombo, M., Perego, P., Giardini, V., Volpe, M., Dell’Oro, R., Mancia, G., & Grassi, G. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02988 · Cited by 80 · see citing works
Self-citationLembo, G., Iaccarino, G., Vecchione, C., Barbato, E., Izzo, R., Fontana, D., & Trimarco, B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119732 · Cited by 73 · see citing works
Self-citationDose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow
Sundell, J., Nuutila, P., Laine, H. K., Luotolahti, M., Kalliokoski, K. K., Raitakari, O. T., & Knuuti, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1125 · Cited by 70 · see citing works
Insulin Sensitivity, Vascular Reactivity, and Clamp-Induced Vasodilatation in Essential Hypertension
Natali, A., Taddei, S., Galvan, A. Q., Camastra, S., Baldi, S., Frascerra, S., Virdis, A., Sudano, I., Salvetti, A., & Ferrannini, E. (1997) · Circulation · doi:10.1161/01.cir.96.3.849 · Cited by 71 · see citing works
Sympathetic Nerve Activity and Insulin in Obese Normotensive and Hypertensive Men
Guðbjörnsdóttir, S., Lönnroth, P., Sverrisdóttir, Y. B., Wallin, B. G., & Elam, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.2.276 · Cited by 65 · see citing works
Insulin, nitric oxide and the sympathetic nervous system
Sartori, C. S., & Scherrer, U. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917110-00003 · Cited by 67 · see citing works
Protogerou, A. D., Blacher, J., Aslangul, E., Jeunne, C. L., Lekakis, J. P., Mavrikakis, M., & Safar, M. E. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.046 · Cited by 65 · see citing works
Insulin and myocardial blood flow
Sundell, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00718-6 · Cited by 65 · see citing works
Insulin/adenosine axis linked signalling
Silva, L., Subiabre, M., Henríquez, J. A., Sáez, T., Salsoso, R., Pardo, F., Leiva, A., Martín, R. S., Toledo, F., & Sobrevía, L. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.002 · Cited by 64 · see citing works
Obesity, hypertension, and sympathetic nervous system activity
Corry, D. B., & Tuck, M. L. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0005-x · Cited by 64 · see citing works
The effects of thiazolidinediones on blood pressure levels – A systematic review
Sarafidis, P. A., & Nilsson, P. M. (2006) · Blood Pressure · doi:10.1080/08037050600853720 · Cited by 64 · see citing works
Insulin Resistance and Cardiovascular Risk: New Insights From Molecular and Cellular Biology
Morisco, C., Lembo, G., & Trimarco, B. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.03.008 · Cited by 63 · see citing works
Self-citationBiventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease
Oflaz, H., Alışır, S., Büyükaydın, B., Kocaman, O., Turgut, F. H., Namli, Ş., Pamukçu, B., Öncül, A., & Ecder, T. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00682.x · Cited by 61 · see citing works
Insights Into the Pathogenesis and Prevention of Coronary Artery Disease
O’Keefe, J. H., Lavie, C. J., & McCallister, B. D. (1995) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64669-7 · Cited by 59 · see citing works
Insulin, Neuropeptide Y, and Food Intake
Schwartz, M. W., Figlewicz, D. P., Woods, S. C., Porte, D., & Baskin, D. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26206.x · Cited by 59 · see citing works
Disparity of autonomic control in type 2 diabetes mellitus
Huggett, R. J., SCOTT, E. M., Gilbey, S. G., Bannister, J., Mackintosh, A., & Mary, D. A. S. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1601-6 · Cited by 56 · see citing works
Abdulla, M. H., Sattar, M. Z. A., & Johns, E. J. (2011) · International Journal of Nephrology · doi:10.4061/2011/934659 · Cited by 57 · see citing works
Karlsson, A.-K., Attvall, S., Jansson, P., Sullivan, L., & Lännroth, P. (1995) · Metabolism · doi:10.1016/0026-0495(95)90289-9 · Cited by 57 · see citing works
Trovati, M., Massucco, P., Mattiello, L., Cavalot, F. L., Mularoni, E., Hahn, A., & Anfossi, G. (1995) · Diabetologia · doi:10.1007/bf00400582 · Cited by 57 · see citing works
McNulty, P. H., Louard, R. J., Deckelbaum, L. I., Zaret, B. L., & Young, L. H. (1995) · Circulation · doi:10.1161/01.cir.92.8.2151 · Cited by 56 · see citing works
Pathophysiological mechanisms underlying the beneficial effects of physical activity in hypertension
Gambardella, J., Morelli, M. B., Wang, X., & Santulli, G. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13804 · Cited by 54 · see citing works
Utriainen, T., Mäkimattila, S., Virkamäki, A., Bergholm, R., & Yki‐Järvinen, H. (1996) · Diabetologia · doi:10.1007/s001250050601 · Cited by 55 · see citing works
Laine, H. K., Nuutila, P., Luotolahti, M., Meyer, C. G., Elomaa, T., Koskinen, P. J., Rönnemaa, T., & Knuuti, J. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6597 · Cited by 54 · see citing works
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans.
Lembo, G., Rendina, V., Iaccarino, G., Lamenza, F., Volpe, M., & Trimarco, B. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.1015 · Cited by 54 · see citing works
Self-citationDevelopments in the management of autosomal dominant polycystic kidney disease
Schrier, R. W. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1617 · Cited by 53 · see citing works
Adenosine Actions are Preserved in Corpus Cavernosum from Obese and Type II Diabetic db/db Mouse
Carneiro, F. S., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Leite, R., Inscho, E. W., Tostes, R. C., & Webb, R. C. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00752.x · Cited by 53 · see citing works
Diabetes and cardiovascular autonomic dysfunction: Application of animal models
Angelis, K. D., Irigoyen, M. C., & Morris, M. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.10.013 · Cited by 51 · see citing works
Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia
Kern, W., Peters, A., Jan Born, A., Fehm, H. L., & Schultes, B. (2005) · Metabolism · doi:10.1016/j.metabol.2004.10.005 · Cited by 50 · see citing works
Insulin Enhances Endothelial α 2 -Adrenergic Vasorelaxation by a Pertussis Toxin Mechanism
Lembo, G., Iaccarino, G., Vecchione, C., Barbato, E., Morisco, C., Monti, F., Parrella, L. S., & Trimarco, B. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1128 · Cited by 51 · see citing works
Self-citationTyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study
Huang, X., He, J., Wu, G., Peng, Z., Yang, B., & Ye, L. (2023) · Diabetes and Vascular Disease Research · doi:10.1177/14791641231173617 · Cited by 49 · see citing works
Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
Lembo, G., Iaccarino, G., Rendina, V., Volpe, M., & Trimarco, B. (1994) · Hypertension · doi:10.1161/01.hyp.24.4.429 · Cited by 49 · see citing works
Self-citationHypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Tagi, V. M., Mainieri, F., & Chiarelli, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105814 · Cited by 47 · see citing works
Familial Hypertension, Insulin, Sympathetic Activity, and Blood Pressure Elevation
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.96 · Cited by 47 · see citing works
Diabetes, body fat, skeletal muscle, and hypertension: The ominous chiasmus?
Shu, J., Matarese, A., & Santulli, G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13453 · Cited by 48 · see citing works
Doyle, P., Cusin, I., Rohner‐Jeanrenaud, F., & Jeanrenaud, B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00402-c · Cited by 46 · see citing works
Dorella, M., Giusto, M., Tos, V. D., Campagnolo, M., Palatini, P., Rossi, G., Ceolotto, G., Felice, M., Semplicini, A., & Prato, S. D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.4.8636369 · Cited by 45 · see citing works
Bergholm, R., Westerbacka, J., Vehkavaara, S., Seppälä‐Lindroos, A., Goto, T., & Yki-Järvinen, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7307 · Cited by 49 · see citing works
Lembo, G., Vecchione, C., Izzo, R., Fratta, L., Fontana, D., Marino, G., Pilato, G., & Trimarco, B. (2000) · Circulation · doi:10.1161/01.cir.102.5.552 · Cited by 44 · see citing works
Self-citationOut-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension
Siddiqui, M., Judd, E. K., Jaeger, B. C., Bhatt, H., Dudenbostel, T., Zhang, B., Edwards, L. J., Oparil, S., & Calhoun, D. A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11818 · Cited by 43 · see citing works
Sundell, J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00375.x · Cited by 41 · see citing works
Lembo, G., Iaccarino, G., Vecchione, C., Rendina, V., & Trimarco, B. (1995) · Hypertension · doi:10.1161/01.hyp.26.2.290 · Cited by 41 · see citing works
Self-citationAutonomic Dysfunction in Diabetes: a Consequence of Cardiovascular Damage
Lefrandt, J. D., Smit, A. J., Zeebregts, C. J., Gans, R. O. B., & Hoogenberg, K. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793499128 · Cited by 38 · see citing works
Benedict, C., Dodt, C., Hallschmid, M., Lepiorz, M., Fehm, H. L., Jan Born, A., & Kern, W. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.026 · Cited by 38 · see citing works
Hypertension, Hyperlipidemia, and Renal Damage
Keane, W. F., Kasiske, B. L., O’Donnell, M. P., & Kim, Y. (1993) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(93)70094-f · Cited by 38 · see citing works
Asensio, C. S., Jimenez, M., Kühne, F., Rohner‐Jeanrenaud, F., & Muzzin, P. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3490 · Cited by 36 · see citing works
Body fat and sympathetic nerve activity
Scherrer, U., Owlya, R., & Leport, M. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00120490 · Cited by 36 · see citing works
Laine, H. K., Knuuti, J. M., Ruotsalainen, U., Raitakari, M., Iida, H., Kapanen, J., Kirvelä, O., Haaparanta‐Solin, M., Yki‐Järvinen, H., & Nuutila, P. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816020-00012 · Cited by 36 · see citing works
Insulin Modulation of β-Adrenergic Vasodilator Pathway in Human Forearm
Lembo, G., Iaccarino, G., Vecchione, C., Rendina, V., Parrella, L., & Trimarco, B. (1996) · Circulation · doi:10.1161/01.cir.93.7.1403 · Cited by 35 · see citing works
Self-citation
- Authors
- Lembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L.
- Affiliations
- Federico II University Hospital (IT)
- Venue
- Journal of Clinical Investigation
- Published
- 1992-07-01
- Volume
- 90
- Issue
- 1
- Pages
- 24-29
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC443058
- OpenAlex
- W2159417090
- Semantic Scholar
- 8fe2d8db2d3c3ab4a67dd67a612135319f91815b
- Cited by
- 252
- References
- 47
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 9 · 2015: 5 · 2014: 6 · 2013: 4 · 2012: 8
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Società Italiana dell'Ipertensione Arteriosa
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- essential hypertension, hyperinsulinemia, insulin resistance, skeletal muscle, sympathetic nervous system, noradrenaline release, glucose uptake
- MeSH terms
- Adult, Female, Humans, Hypertension, Insulin, Male, Muscles, Norepinephrine, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review